Lixisenatide for type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Lixisenatide for type 2 diabetes mellitus

Published:2011-03-11 Issue:4 Volume:20 Page:549-557
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Christensen Mikkel¹,Knop Filip K¹,Vilsbøll Tina¹,Holst Jens J²

Affiliation:

1. University of Copenhagen, Gentofte Hospital, Diabetes Research Division, Department of Internal Medicine F, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark ; ;

2. Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2011.562191

Reference39 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030

2. Islet cell function: α and β cells - partners towards normoglycaemia

3. Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?

4. Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

5. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-22

2. Causal Association Between Type 2 Diabetes Mellitus and Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study;Journal of Alzheimer's Disease Reports;2024-06-18

3. Anti-inflammatory benefits of semaglutide: State of the art;Journal of Clinical & Translational Endocrinology;2024-06

4. Non‐insulin Parenteral Therapies;Textbook of Diabetes;2024-01-12

5. DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson’s Disease Rat Model;Parkinson's Disease;2022-11-14